Skip to main content
. 2011 Sep 9;2(6):679–698. doi: 10.1007/s13244-010-0062-3

Fig. 16.

Fig. 16

18F-FDG PET-CT performed in a 52-year-old female with breast cancer and chronic hepatitis. On the CT component a hyper-enhancing mass is identified in segment 4 of the liver (yellow arrow). No increased FDG activity is identified in this area on the PET component. Biopsy of the mass confirmed the diagnosis of a hepatocellular carcinoma